TABLE 2

Surgical and cancer characteristics of the study population stratified by compliance to the 6-month follow-up protocol

BaselineCompleted 6-month follow-upDropout at 6 months
Patients806515
VATS46 (58)34 (52)12 (80)
Resection degree
 Wedge resection/segmentectomy26 (33)17 (26)9 (60)
 Lobectomy45 (56)39 (60)6 (33)
 Bilobectomy3 (4)3 (5)0
 Pneumonectomy6 (7)6 (9)0
Duration of surgery min132±60 120 (30–320)136±58 120 (45–320)99±47 95 (30–150)
Duration of chest tubes h68±77 29 (8–360)74±83 33 (8–360)44±48 24 (11–172)
Length of hospital stay# days8±5 6 (3–30)8±5 6 (3–25)7±7 5 (3–30)
Post-operative chemotherapy20 (25)19 (29)1 (7)
Cancer characteristics
 NSCLC54 (67)47 (72)7 (47)
  Stage IA/IB13/18 (24/34)11/15 (23.5/32)2/3 (28.5/43)
  Stage IIA/IIB1/11 (2/20)1/9 (2/19)0/2 (0/28.5)
  Stage IIIA11 (20)11 (23.5)0
 Metastatic tumour11 (14)10 (16)1 (6)
 Nonmalignancy15 (19)8 (12)7 (47)

Values are presented as n, n (%), mean±sd or median (minimum–maximum range). VATS: video-assisted thoracoscopic surgery; NSCLC: nonsmall cell lung cancer. #: length of hospital stay includes transfer to other units; : data refer only to NSCLC.